Concurrent palliative chemoradiation leads to survival and quality of life benefits in poor prognosis stage III non-small-cell lung cancer: a randomised trial by the Norwegian Lung Cancer Study Group - Strøm, H; Bremnes, R; Sundstrøm, S (Br J Cancer, 2013)
et al.